In the RB-deficient MDA-MB-468 xenograft mouse model, Palbociclib alone didn’t significantly suppress tumor growth, as expected, but the combination of Sulfopin and Palbociclib elicited a complete inhibition of tumor growth (Fig. 6j, k). Here, RB1 is linked to neoplasm.